StockData
Camtek Ltd logo

Camtek Ltd (CAMT) stock analysis

CAMTNasdaqOptical Instruments & LensesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 12/30
$105.42−1.63 (-1.52%)

Close on Nov 12, 2026Market cap $4.83BP/E 101.4Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth3Performance4Health5Dividend0

Mixed12 of 30 checks passed

Camtek passes 12 of the 30 checks behind our score; 13 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
3/6
Past performance
4/6
Financial health
5/6
Dividend
0/6

What stands out

  • Return on capital over 10%

    Return on invested capital was 33.0%, above the 10% that usually covers the cost of capital.

  • No debt

    Camtek has no borrowings on its latest balance sheet.

  • Earnings grew over 5 years

    Net income grew 18.4% a year on average over the last five fiscal years.

  • Revenue growing 10%+ a year

    Revenue grew 15.6% a year over the last three fiscal years.

What to watch

  • Return on equity under 15%

    Return on equity was 8.7% over the last twelve months and averaged 19.4% over five years; we look for 15% on both.

  • EPS growing under 10% a year

    Diluted EPS grew -14.8% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -57.2% over the last twelve months, against a 5-year average of 18.4% a year.

  • Net margin below its 5-year average

    Net margin was 10.2% over the last twelve months, against a 5-year average of 22.0%.

Valuation0/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B against the industry

    Needs positive book value.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth3/6

  • Revenue growing 10%+ a year

    Revenue grew 15.6% a year over the last three fiscal years.

  • EPS growing under 10% a year

    Diluted EPS grew -14.8% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -57.2% over the last twelve months, against a 5-year average of 18.4% a year.

  • Growing faster than the industry

    Revenue grew 15.6% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin improving

    Gross margin was 50.5% over the last twelve months, against 48.9% a year earlier.

Past performance4/6

  • Return on equity under 15%

    Return on equity was 8.7% over the last twelve months and averaged 19.4% over five years; we look for 15% on both.

  • Return on capital over 10%

    Return on invested capital was 33.0%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Camtek's return on equity of 8.7% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings grew over 5 years

    Net income grew 18.4% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 10.2% over the last twelve months, against a 5-year average of 22.0%.

  • Net margin above the industry

    Camtek's net margin of 10.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Financial health5/6

  • No debt

    Camtek has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 8.35 times current liabilities.

  • Bankruptcy risk (Altman Z)

    Needs market value, working capital and retained earnings.

Dividend0/6

  • No dividend

    Camtek has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for Camtek. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$76.67M
Value traded per 1% price move
$16.92M

Downside

High risk

Typical loss in a bad month
30.2%
Volatility (annualized)
72%
Sharpe ratio, 1 year
-0.11
Beta to the S&P 500 (5Y)
1.77

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

50.5%+3.5 pts over 5 years

Operating margin

25.8%+11.3 pts over 5 years

Net margin

10.2%−3.7 pts over 5 years

See a number that looks wrong?